Bioverativ Reports Second Quarter 2017 Performance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/29/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- Bloom Energy shares fall on Oracle project halt
- Exclusive-Activist Jana pushes Fiserv to accelerate cost cuts and tap Palantir
- Stocks fall as higher oil prices, Treasury yields weigh
Bioverativ Inc. (BIVV) Tops Q2 EPS by 17c
August 2, 2017 4:51 PM EDTBioverativ Inc. (NASDAQ: BIVV) reported Q2 EPS of $0.88, $0.17 better than the analyst estimate of $0.71. Revenue for the quarter came in at $289.1 million versus the consensus estimate of $268 million.
For earnings history and earnings-related data on Bioverativ Inc. (BIVV) click here.
... More